• A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

    Not yet recruiting

    3 1 1
    Czechia Denmark France Germany Hungary Italy +3
  • Study of ketamine hydrochloride to improve recovery in adults requiring unplanned mechanical ventilation in the intensive care unit

    Not yet recruiting

    4 1 1
    Investigated diseases:
    France
  • Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    France Italy The Netherlands Spain
  • Carboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease

    Not yet recruiting

    2 1 1 1
    France
  • Contraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets

    Not yet recruiting

    3 1 1 1
    Finland
  • Evaluating measles, mumps, rubella vaccine (live) in lactating women to enhance infant mucosal immunity

    Not yet recruiting

    3 1 1 1
    Belgium
  • Effect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Greece
  • Phase 3 Study of INCB123667 versus investigator’s choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Ireland Italy The Netherlands +2
  • Feasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland France Germany Italy Poland +2

powered by